NPI: 1154399491 · TALLAHASSEE, FL 32304 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,985 | $5.03M |
| 2019 | 34,063 | $5.92M |
| 2020 | 38,167 | $5.24M |
| 2021 | 25,158 | $2.86M |
| 2022 | 15,541 | $1.81M |
| 2023 | 9,806 | $490K |
| 2024 | 5,190 | $335K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 48,861 | 3,178 | $7.40M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 48,449 | 2,366 | $6.32M |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,471 | 1,887 | $3.24M |
| A4657 | Syringe, with or without needle, each | 6,668 | 2,369 | $1.31M |
| J1756 | Injection, iron sucrose, 1 mg | 7,316 | 1,510 | $802K |
| 83970 | 2,393 | 1,542 | $368K | |
| 85041 | 2,374 | 1,630 | $366K | |
| 85048 | 2,372 | 1,629 | $365K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,550 | 528 | $356K |
| 83540 | 1,989 | 1,364 | $302K | |
| 83550 | 1,989 | 1,362 | $302K | |
| 82728 | 1,921 | 1,308 | $291K | |
| 82108 | 562 | 422 | $93K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 509 | 292 | $81K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 321 | 119 | $30K |
| 90674 | 75 | 67 | $18K | |
| G0008 | Administration of influenza virus vaccine | 90 | 81 | $18K |